Portfolio company
Endometrics
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
Endometrics develops non-invasive diagnostic tests using menstrual blood samples and genomic biomarkers to detect endometriosis for women and healthcare providers.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Endogene.Bio
This company develops a biological data platform using menstrual blood to provide diagnostics and patient stratification tools for pharmaceutical firms and healthcare providers.
Afynia
This company develops non-invasive blood tests to diagnose endometriosis for women and fertility clinics.
Genie
This company develops non-invasive diagnostics using menstrual blood to study uterine molecular biomarkers for patients experiencing infertility.
Metri
This biotechnology company develops organoid-based human models to create therapeutics for patients with uterine and endometrial diseases.
Scanvio
Scanvio develops AI-based ultrasound software to assist clinicians in the earlier and more accurate diagnosis of endometriosis for healthcare providers.
Mimark
The company develops protein-based diagnostic tests using gynecological fluids to identify diseases for patients, clinicians and healthcare systems.
Unravel Health
This company develops a palm-sized device for monitoring multiple hormones from saliva samples at home for women and clinical research partners.
Scanvio Medical
This company develops AI-guided ultrasound software to help gynecologists and medical centers diagnose endometriosis through real-time image analysis during standard pelvic examinations.
